•
NP
NPCE
Neuropace, Inc. Common Stock
yahooSURGICAL & MEDICAL INSTRUMENTS & APPARATUS
--
Price Chart
Market Cap
564.23M
Volume
161.51K
52W High
$18.98
52W Low
$7.56
Open
$0.00
Prev Close
$16.52
Day Range
0.00 - 0.00
About Neuropace, Inc. Common Stock
NeuroPace Inc is a commercial-stage medical device company focused on transforming the lives of people suffering from epilepsy by reducing or eliminating the occurrence of debilitating seizures. It derives substantially all of its revenue from the sales of RNS Systems to hospital facilities (typically Level 4 CECs) that implant RNS Systems.
Latest News
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of NeuroPace, Inc. - NPCE
GlobeNewswire Inc.•May 28
UPDATE – NeuroPace to Present at the Leerink Partners Global Healthcare Conference
GlobeNewswire Inc.•Mar 4
Neuroscience Market Projected to Reach USD 50.2 Billion by 2032, Growing at a 4.0% CAGR – S&S Insider
GlobeNewswire Inc.•Nov 11
Globus Medical (GMED) Q1 Earnings and Revenues Beat Estimates
Zacks Investment Research•May 7
NeuroPace to Report First Quarter 2024 Financial Results on May 8, 2024
GlobeNewswire Inc.•Apr 17
NeuroPace to Present at the Needham 23rd Annual Healthcare Conference
GlobeNewswire Inc.•Mar 27
The Latest Analyst Ratings For NeuroPace
Benzinga•Mar 12
NeuroPace Announces Record Full Year 2023 Revenue of $65.4 Million
GlobeNewswire Inc.•Mar 5